Showing 27 of 27 results
Number of displayed results:
- STARR-seq in K562Homo sapiens K562 genetically modified (episome) using transient transfectionElements selection method: accessible genome regionsLab: Tim Reddy, DukeProject: ENCODE
- STARR-seq in K562Homo sapiens K562 genetically modified (episome) using transient transfectionElements selection method: accessible genome regionsLab: Tim Reddy, DukeProject: ENCODE
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM ZK216348 (agonist) for 4 hoursLab: Tim Reddy, DukeProject: ENCODETreatment: 1 μM ZK216348 for 4 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM RU486 (antagonist) for 4 hoursLab: Tim Reddy, DukeProject: ENCODETreatment: 1 μM RU486 for 4 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM Mapracorat (agonist) for 4 hoursLab: Tim Reddy, DukeProject: ENCODETreatment: 1 μM Mapracorat for 4 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM Hydrocortisone (agonist) for 4 hoursLab: Tim Reddy, DukeProject: ENCODETreatment: 1 μM Hydrocortisone for 4 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM GW870086 (agonist) for 4 hoursLab: Tim Reddy, DukeProject: ENCODETreatment: 1 μM GW870086 for 4 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfectionLab: Tim Reddy, DukeProject: ENCODE
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM dexamethasone (agonist) for 4 hoursLab: Tim Reddy, DukeProject: ENCODETreatment: 1 μM dexamethasone (CHEBI:41879) for 4 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hoursLab: Tim Reddy, DukeProject: ENCODETreatment: 1 μM CpdA for 4 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM CORT108297 (antagonist) for 4 hoursLab: Tim Reddy, DukeProject: ENCODETreatment: 1 μM CORT108297 for 4 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM AZD9567 (agonist) for 4 hoursLab: Tim Reddy, DukeProject: ENCODETreatment: 1 μM AZD9567 for 4 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM AZD2906 (agonist) for 4 hoursLab: Tim Reddy, DukeProject: ENCODETreatment: 1 μM AZD2906 for 4 hours
- STARR-seq in K562Homo sapiens K562 genetically modified (episome) using transient transfectionLab: Tim Reddy, DukeProject: ENCODE
- STARR-seq in K562Single human gDNA fragments and concatenated pairs of such fragments were tested for their enhancer activity with eSTARR-seq. The RNAs derived from the transfected plasmids were sequenced and reported here.Elements selection method: transcription start sitesLab: Haiyuan Yu, CornellProject: ENCODE
- STARR-seq in K562Human gDNA fragments were selected based on DHS data, GRO-cap data, and/or histone marks in K562 cells and tested for their enhancer activity with eSTARR-seq. The RNAs derived from the transfected plasmids were sequenced and reported here.Elements selection method: DNase hypersensitive sites, transcription start sites, chromatin statesLab: Haiyuan Yu, CornellProject: ENCODE
- STARR-seq in K562Human gDNA fragments were selected based on DHS data, GRO-cap data, and/or histone marks in K562 cells and tested for their enhancer activity with eSTARR-seq. The RNAs derived from the transfected plasmids were sequenced and reported here.Elements selection method: DNase hypersensitive sites, transcription start sites, chromatin statesLab: Haiyuan Yu, CornellProject: ENCODE
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 100 nM dexamethasone (agonist) for 12 hoursLab: Tim Reddy, DukeProject: GGRTreatment: 100 nM dexamethasone (CHEBI:41879) for 12 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 100 nM dexamethasone (agonist) for 8 hoursLab: Tim Reddy, DukeProject: GGRTreatment: 100 nM dexamethasone (CHEBI:41879) for 8 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 100 nM dexamethasone (agonist) for 4 hoursLab: Tim Reddy, DukeProject: GGRTreatment: 100 nM dexamethasone (CHEBI:41879) for 4 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 100 nM dexamethasone (agonist) for 1 hourLab: Tim Reddy, DukeProject: GGRTreatment: 100 nM dexamethasone (CHEBI:41879) for 1 hour
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfectionLab: Tim Reddy, DukeProject: GGR
- STARR-seq in MCF-7Homo sapiens MCF-7 genetically modified (episome) using transient transfectionLab: Kevin White, UChicagoProject: ENCODE
- STARR-seq in HCT116Homo sapiens HCT116 genetically modified (episome) using transient transfectionLab: Kevin White, UChicagoProject: ENCODE
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfectionLab: Kevin White, UChicagoProject: ENCODE
- STARR-seq in HepG2Homo sapiens HepG2 genetically modified (episome) using transient transfectionLab: Kevin White, UChicagoProject: ENCODE
- STARR-seq in K562Homo sapiens K562 genetically modified (episome) using transient transfectionLab: Kevin White, UChicagoProject: ENCODE